Chimeric Therapeutics Ltd
ASX:CHM

Watchlist Manager
Chimeric Therapeutics Ltd Logo
Chimeric Therapeutics Ltd
ASX:CHM
Watchlist
Price: 0.004 AUD Market Closed
Market Cap: 7.4m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+183%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

CHM Price Targets Summary
Chimeric Therapeutics Ltd

There are no price targets for CHM.
CHM Lowest Forecast
Wall Street Target
Not Available
CHM Average Forecast
Wall Street Target
Not Available
CHM Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Chimeric Therapeutics Ltd Competitors:
Price Targets
H
145020
Hugel Inc
18% Upside
TNG
Transgene SA
94% Upside
BSLN
Basilea Pharmaceutica AG
84% Upside
EXAS
Exact Sciences Corp
33% Upside
H
145020
Hugel Inc
18% Upside
TNG
Transgene SA
94% Upside
BSLN
Basilea Pharmaceutica AG
84% Upside
EXAS
Exact Sciences Corp
33% Upside
J
7774
Japan Tissue Engineering Co Ltd
104% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
29% Upside
ORY
Oryzon Genomics SA
170% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
30% Upside

Revenue
Forecast

Revenue Estimate
Chimeric Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Chimeric Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Chimeric Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-79%
Average Miss
What are analyst estimates?

See Also

Summary
CHM intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHM stock valuation using valuation multiples.
Wall Street Estimates
CHM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CHM's stock price target?
Not Available

CHM doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.